Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 105

1.

Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment.

Gałecki P, Szemraj J, Bieńkiewicz M, Florkowski A, Gałecka E.

Pharmacol Rep. 2009 May-Jun;61(3):436-47.

2.

Oxidative stress parameters after combined fluoxetine and acetylsalicylic acid therapy in depressive patients.

Gałecki P, Szemraj J, Bieńkiewicz M, Zboralski K, Gałecka E.

Hum Psychopharmacol. 2009 Jun;24(4):277-86. doi: 10.1002/hup.1014.

PMID:
19319921
3.

Antioxidant potential of fluoxetine in comparison to Curcuma longa in restraint-stressed rats.

Zafir A, Banu N.

Eur J Pharmacol. 2007 Oct 15;572(1):23-31. Epub 2007 Jun 13.

PMID:
17610875
4.

Lipid peroxidation and antioxidant enzyme activities in erythrocytes of type 2 diabetic patients.

Likidlilid A, Patchanans N, Peerapatdit T, Sriratanasathavorn C.

J Med Assoc Thai. 2010 Jun;93(6):682-93.

PMID:
20572373
5.

Nitric oxide and lipid peroxidation are increased and associated with decreased antioxidant enzyme activities in patients with age-related macular degeneration.

Evereklioglu C, Er H, Doganay S, Cekmen M, Turkoz Y, Otlu B, Ozerol E.

Doc Ophthalmol. 2003 Mar;106(2):129-36.

PMID:
12678277
6.

Oxidative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors.

Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R.

Redox Rep. 2003;8(6):365-70.

PMID:
14980069
7.

Oxidative stress and antioxidant parameters in patients with major depressive disorder compared to healthy controls before and after antidepressant treatment: results from a meta-analysis.

Jiménez-Fernández S, Gurpegui M, Díaz-Atienza F, Pérez-Costillas L, Gerstenberg M, Correll CU.

J Clin Psychiatry. 2015 Dec;76(12):1658-67. doi: 10.4088/JCP.14r09179.

PMID:
26579881
8.

The relevance of oxidative stress status in first episode and recurrent depression.

Stefanescu C, Ciobica A.

J Affect Disord. 2012 Dec 20;143(1-3):34-8. doi: 10.1016/j.jad.2012.05.022. Epub 2012 Jul 25.

PMID:
22840610
9.

Fluoxetine decreases concentrations of 3 alpha, 5 alpha-tetrahydrodeoxycorticosterone (THDOC) in major depression.

Ströhle A, Pasini A, Romeo E, Hermann B, Spalletta G, di Michele F, Holsboer F, Rupprecht R.

J Psychiatr Res. 2000 May-Jun;34(3):183-6.

PMID:
10867112
10.

Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study.

Kotan VO, Sarandol E, Kirhan E, Ozkaya G, Kirli S.

Prog Neuropsychopharmacol Biol Psychiatry. 2011 Jul 1;35(5):1284-90. doi: 10.1016/j.pnpbp.2011.03.021. Epub 2011 Apr 15.

PMID:
21515329
11.

[Lipid peroxidation and copper-zinc superoxide dismutase activity in patients treated with fluoxetine during the first episode of depression].

Gałecki P, Kedziora J, Florkowski A, Gałecka E.

Psychiatr Pol. 2007 Sep-Oct;41(5):615-24. Polish.

PMID:
18421918
12.

Markers of antioxidant defence system and lipid peroxidation in peripheral blood of female patients with chronic idiopathic urticaria.

Kasperska-Zajac A, Brzoza Z, Polaniak R, Rogala B, Birkner E.

Arch Dermatol Res. 2007 Mar;298(10):499-503.

PMID:
17171548
13.

Antioxidant enzyme activities and lipid peroxidation levels in erythrocytes of patients with oesophageal and gastric cancer.

Dursun H, Bilici M, Uyanik A, Okcu N, Akyüz M.

J Int Med Res. 2006 Mar-Apr;34(2):193-9.

PMID:
16749415
14.
15.

Major depressive disorder is accompanied with oxidative stress: short-term antidepressant treatment does not alter oxidative-antioxidative systems.

Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S.

Hum Psychopharmacol. 2007 Mar;22(2):67-73.

PMID:
17299810
16.

Antioxidant enzyme activities and malondialdehyde levels in patients with obsessive-compulsive disorder.

Kuloglu M, Atmaca M, Tezcan E, Gecici O, Tunckol H, Ustundag B.

Neuropsychobiology. 2002;46(1):27-32.

PMID:
12207144
17.
18.

Antioxidant enzyme activities and oxidative stress in affective disorders.

Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O.

Int Clin Psychopharmacol. 2004 Mar;19(2):89-95.

PMID:
15076017
19.

Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxidative damage induced by chronic unpredictable stress.

Moretti M, Colla A, de Oliveira Balen G, dos Santos DB, Budni J, de Freitas AE, Farina M, Severo Rodrigues AL.

J Psychiatr Res. 2012 Mar;46(3):331-40. doi: 10.1016/j.jpsychires.2011.11.009. Epub 2011 Dec 9.

PMID:
22154133
20.

Lipid peroxidation and antioxidant enzymes in children on maintenance dialysis.

Zwołińska D, Grzeszczak W, Szczepańska M, Kiliś-Pstrusińska K, Szprynger K.

Pediatr Nephrol. 2006 May;21(5):705-10. Epub 2006 Mar 4.

PMID:
16518626

Supplemental Content

Support Center